Showing 401 - 420 results of 534 for search '(( significant decrease decrease ) OR ( ((significant event) OR (significant effect)) decrease ))~', query time: 0.51s Refine Results
  1. 401

    Epidemiological analysis of SARS-CoV-2 variants in Saudi Arabia by Mohamed A. Farrag (22769757)

    Published 2025
    “…These factors have a significant effect on the rate of infections caused by breathing-related diseases such as Coronavirus disease 2019 (COVID-19) in the country. …”
  2. 402

    Data Sheet 1_Modeling lymphocyte subset dynamics after ublituximab therapy in patients with multiple sclerosis: an Italian prospective study.pdf by Aurora Zanghì (9202094)

    Published 2025
    “…</p>Results<p>A total cohort of 16 patients was enrolled, with a median age of 47 (Q1–Q3 41–58), 69% men, median EDSS of 4.5, and median body mass index (BMI) of 26.9 kg/m<sup>2</sup>. Mixed-effects models showed a significant effect of time on all lymphocyte subsets. …”
  3. 403

    Table 2_Temporary trigeminal ganglion stimulation can improve zoster-related trigeminal neuralgia: a retrospective study in a single center.docx by Kan Yue (1378518)

    Published 2025
    “…At the six-month follow-up, the mean VAS score decreased from preoperative 6.1 ± 1.5 to 2.5 ± 1.9, demonstrating a statistically significant reduction (t = 4.36, p < 0.05). …”
  4. 404

    Table 1_Temporary trigeminal ganglion stimulation can improve zoster-related trigeminal neuralgia: a retrospective study in a single center.docx by Kan Yue (1378518)

    Published 2025
    “…At the six-month follow-up, the mean VAS score decreased from preoperative 6.1 ± 1.5 to 2.5 ± 1.9, demonstrating a statistically significant reduction (t = 4.36, p < 0.05). …”
  5. 405

    Image 2_Temporary trigeminal ganglion stimulation can improve zoster-related trigeminal neuralgia: a retrospective study in a single center.tif by Kan Yue (1378518)

    Published 2025
    “…At the six-month follow-up, the mean VAS score decreased from preoperative 6.1 ± 1.5 to 2.5 ± 1.9, demonstrating a statistically significant reduction (t = 4.36, p < 0.05). …”
  6. 406

    Image 1_Temporary trigeminal ganglion stimulation can improve zoster-related trigeminal neuralgia: a retrospective study in a single center.tif by Kan Yue (1378518)

    Published 2025
    “…At the six-month follow-up, the mean VAS score decreased from preoperative 6.1 ± 1.5 to 2.5 ± 1.9, demonstrating a statistically significant reduction (t = 4.36, p < 0.05). …”
  7. 407

    Potential benefits and neural correlates of adjunctive acupuncture therapyin unilateral stroke rehabilitation by Jia Fan (20107030)

    Published 2024
    “…Stroke-rehabilitation programmes are highly effective to regain independence and quality of life (QoL). …”
  8. 408

    Image 2_Evaluating dexmedetomidine in mitigating emergence agitation and perioperative complications in pediatric tonsillectomy and/or adenoidectomy: a systematic review and meta-a... by Jihong He (3527105)

    Published 2025
    “…Subgroup analysis of delivery methods, timing, and dosage (Dex ≥0.5 μg/kg) indicated that Dex significantly decreased the incidence of EA (P < 0.05). …”
  9. 409

    Image 1_Evaluating dexmedetomidine in mitigating emergence agitation and perioperative complications in pediatric tonsillectomy and/or adenoidectomy: a systematic review and meta-a... by Jihong He (3527105)

    Published 2025
    “…Subgroup analysis of delivery methods, timing, and dosage (Dex ≥0.5 μg/kg) indicated that Dex significantly decreased the incidence of EA (P < 0.05). …”
  10. 410

    Data Sheet 1_Yerba Maté and its impact on glycemic control and metabolic health: a systematic review and meta-analysis.docx by Daiping Li (5007932)

    Published 2025
    “…No significant effects were found on triglycerides, total cholesterol, HDL-C, LDL-C, fasting glucose, fasting insulin, waist circumference, or BMI. …”
  11. 411

    Data Sheet 3_Yerba Maté and its impact on glycemic control and metabolic health: a systematic review and meta-analysis.doc by Daiping Li (5007932)

    Published 2025
    “…No significant effects were found on triglycerides, total cholesterol, HDL-C, LDL-C, fasting glucose, fasting insulin, waist circumference, or BMI. …”
  12. 412

    Data Sheet 2_Yerba Maté and its impact on glycemic control and metabolic health: a systematic review and meta-analysis.docx by Daiping Li (5007932)

    Published 2025
    “…No significant effects were found on triglycerides, total cholesterol, HDL-C, LDL-C, fasting glucose, fasting insulin, waist circumference, or BMI. …”
  13. 413

    Data Sheet 1_Impact of mini-dose dexmedetomidine supplemented analgesia on sleep structure in patients at high risk of obstructive sleep apnea: a pilot trial.docx by Pei Sun (115160)

    Published 2024
    “…</p>Objectives<p>To investigate the effect of mini-dose dexmedetomidine supplemented analgesia on postoperative sleep quality pattern in patients at high risk of OSA.…”
  14. 414

    Image 2_Nusinersen for children with type I spinal muscular atrophy: 4 years’ clinical experience in Turkish cohort.jpeg by Ömer Bektaş (13827139)

    Published 2025
    “…Ventilator and gastrostomy requirements decreased in the early treated cohorts. Adverse events were rare, with one discontinuation due to hydrocephalus. …”
  15. 415

    Table 1_Nusinersen for children with type I spinal muscular atrophy: 4 years’ clinical experience in Turkish cohort.docx by Ömer Bektaş (13827139)

    Published 2025
    “…Ventilator and gastrostomy requirements decreased in the early treated cohorts. Adverse events were rare, with one discontinuation due to hydrocephalus. …”
  16. 416

    Image 1_Nusinersen for children with type I spinal muscular atrophy: 4 years’ clinical experience in Turkish cohort.jpeg by Ömer Bektaş (13827139)

    Published 2025
    “…Ventilator and gastrostomy requirements decreased in the early treated cohorts. Adverse events were rare, with one discontinuation due to hydrocephalus. …”
  17. 417

    Table 7_Nusinersen for children with type I spinal muscular atrophy: 4 years’ clinical experience in Turkish cohort.docx by Ömer Bektaş (13827139)

    Published 2025
    “…Ventilator and gastrostomy requirements decreased in the early treated cohorts. Adverse events were rare, with one discontinuation due to hydrocephalus. …”
  18. 418

    Table 6_Nusinersen for children with type I spinal muscular atrophy: 4 years’ clinical experience in Turkish cohort.docx by Ömer Bektaş (13827139)

    Published 2025
    “…Ventilator and gastrostomy requirements decreased in the early treated cohorts. Adverse events were rare, with one discontinuation due to hydrocephalus. …”
  19. 419

    Table 2_Nusinersen for children with type I spinal muscular atrophy: 4 years’ clinical experience in Turkish cohort.docx by Ömer Bektaş (13827139)

    Published 2025
    “…Ventilator and gastrostomy requirements decreased in the early treated cohorts. Adverse events were rare, with one discontinuation due to hydrocephalus. …”
  20. 420

    Table 4_Nusinersen for children with type I spinal muscular atrophy: 4 years’ clinical experience in Turkish cohort.docx by Ömer Bektaş (13827139)

    Published 2025
    “…Ventilator and gastrostomy requirements decreased in the early treated cohorts. Adverse events were rare, with one discontinuation due to hydrocephalus. …”